Autoimmune Disease Diagnostics Market - Global Industry
Insights, Trends, Outlook, and Opportunity Analysis,
2018-2026
The immune system of human body recognize some invaders such as bacteria, viruses, and
external chemicals and attacks those to protect the body. However, sometimes the immune
system attacks the healthy cells of body by considering them as foreign cells. Such a condition
is called autoimmune disease. The autoimmune disease causes abnormal organ growth and
changes in organ function. The genes of an individual with environmental exposure might be
the major reason for autoimmune disease development. Some of the common autoimmune
diseases among over 80 types of autoimmune diseases are type 1 diabetes, systemic lupus
erythematosus, inflammatory bowel disease, rheumatoid arthritis. The curing therapy for
autoimmune diseases is not yet available only relieving treatments are available for this
diseases. Diagnosis of the autoimmune diseases can be done by the tests which involves
antinuclear antibody test, antibody test, complete blood counts and some others.
For In depth Information Get Sample Copy of this Report @
https://www.coherentmarketinsights.com/insight/request-sample/419
The growing incidences of autoimmune diseases and government initiatives to boost the
autoimmune disease diagnostics market
According to American Autoimmune Related Disease Association (AARDA), in 2016, around 50
million people suffered from autoimmune diseases in the U.S. with 75% being women.
Increasing incidence of autoimmune diseases, rising public awareness and government initiatives
taken to spend the budget on diagnosis and care services for autoimmune diseases, are some of
the factors which are driving the autoimmune disease diagnostics market. Many of the
organizations and governments are funding the research and development program for
autoimmune diseases, this will help to launch the new products in the market and definitely
help in the growth of autoimmune disease diagnostics industry. For instance, the discovery of
novel biomarkers, which has proven to be significant to improve the diagnosis of autoimmune
diseases is also one of the major factor driving the autoimmune diseases diagnostic market.